NASDAQ
BioVaxys Technology Corp. (BVAXF) has a eps (diluted) of $-0.20 as of Thursday, October 31, 2024. Diluted EPS accounts for all potential shares from stock options and convertible securities, providing a more conservative earnings-per-share measure.
No price data available for this timeframe.